Why Is Life Expectancy Falling in US?

By A Thompson. J Evans, & M Stobbe – Re-Blogged From VOA Learning English

Suicides and drug overdoses are two reasons for a continuing decrease in how long Americans are expected to live.

The Centers for Disease Control and Prevention reported recently that there were more than 2.8 million deaths in the United States in 2017. Of those, 47,000 were suicides and 70,000 were drug overdoses.

If you want to understand why life expectancy is decreasing in America, the state of West Virginia may offer some answers.

Maggie Hill, 67, poses for a portrait with a 10-year-old Charity in Madison, W.Va., on Thursday, Nov. 29, 2018. The grandmother is raising Charity, the daughter of Maggie's son, as her own child. (AP Photo/Tyler Evert)
Maggie Hill, 67, poses for a portrait with a 10-year-old Charity in Madison, W.Va., on Thursday, Nov. 29, 2018. The grandmother is raising Charity, the daughter of Maggie’s son, as her own child. (AP Photo/Tyler Evert)

Continue reading

Advertisements

Drug Cuts Breast Cancer Return in Half

By Health Day – Re-Blogged From Newsmax Health

For certain women with early stage breast cancer, a newer drug that combines an antibody with chemotherapy may cut the risk of disease recurrence in half, a new trial finds.

The study focused on nearly 1,500 women with early stage breast cancer that was HER2-positive — meaning it carries a protein that promotes cancer growth.

About one in every five breast cancers is HER2-positive.

Drug Cuts Breast Cancer Return in Half

New Drug Combination Hailed as Cystic Fibrosis Breakthrough

By Health Day – Re-Blogged From Newsmax

In what researchers are calling a “breakthrough,” two preliminary trials have found that either of two triple-drug regimens could potentially benefit 90 percent of people with cystic fibrosis.

The trials were short-term, finding that the drug combinations improved adult patients’ lung function over four weeks. But experts said they were optimistic the results will hold up in the larger, longer-term trials already underway.

Continue reading

Early Results Boost Hopes for Historic Gene Editing Attempt

By Associated Press – Re-Blogged From Newsmax

Early, partial results from a historic gene editing study give encouraging signs that the treatment may be safe and having at least some of its hoped-for effect, but it’s too soon to know whether it ultimately will succeed.

The results announced Wednesday are from the first human test of gene editing in the body, an attempt to permanently change someone’s DNA to cure a disease — in this case, a genetic disorder called Hunter syndrome that often kills people in their teens.

Continue reading

New Drug Offers Hope of Alzheimer’s Breakthrough

By HealthDay – Re-Blogged From Newsmax Health

There have been many setbacks on the long road to finding a treatment that might slow or stop Alzheimer’s disease, but a new trial offers a glimmer of hope.

Researchers report that an experimental drug called BAN2401 slowed mental decline by as much as 30 percent in Alzheimer’s patients. It also appeared to clear away the amyloid protein plaques in the brain that have long been linked to the devastating illness.

Continue reading

Japan Scientists to Use ‘Reprogrammed’ Stem Cells to Fight Parkinson’s

By Thomson Reuters – Re-Blogged From Newsmax Health

TOKYO – Japanese scientists said Monday they will start clinical trials next month on a treatment for Parkinson’s disease, transplanting “reprogrammed” stem cells into brains, seeking a breakthrough in treating the neurodegenerative disorder.

Parkinson’s is caused by a lack of dopamine made by brain cells and researchers have long hoped to use stem cells to restore normal production of the neurotransmitter chemical.

Experimental Drug Halts Parkinson’s Progression

By Clyde Hughes – Re-Blogged From Newsmax Health

An experimental drug developed by Johns Hopkins University researchers appears to slow down the progression of Parkinson’s disease and its symptoms in mice, a statement from the university said this week.

The researchers said that the drug called NLY01 has been proven in studies to block the degradation of brain cells that is the leading cause of Parkinson’s disease. The treatment has been used in the past to treat diabetes, researchers said in the university statement.

Continue reading